Pediatrix Medical (MD) Common Equity (2009 - 2026)

Pediatrix Medical (MD) has reported Common Equity for 18 consecutive years, with $878.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Common Equity rose 11.33% year-over-year to $878.6 million; the TTM figure through Mar 2026 stood at $878.6 million (up 11.33% YoY), while the FY2025 annual figure was $865.9 million, up 13.19% from the prior year.
• Common Equity climbed to $878.6 million in Q1 2026 per MD's latest filing, from $865.9 million in the prior quarter.
• Across five years, Common Equity topped out at $968.0 million in Q3 2023 and bottomed at $706.5 million in Q2 2024.
• Historically, Common Equity has averaged $850.6 million across 5 years, with a median of $858.7 million in 2022.
• Annual changes were most pronounced in 2024 — Common Equity slipped 25.03% — and 2025, when it climbed 21.59%.
• Pediatrix Medical's Common Equity stood at $891.6 million in 2022, then dropped by 4.77% to $849.1 million in 2023, then dropped by 9.91% to $764.9 million in 2024, then grew by 13.19% to $865.9 million in 2025, then grew by 1.47% to $878.6 million in 2026.
• Business Quant data shows MD's Common Equity at $878.6 million in Q1 2026, $865.9 million in Q4 2025, and $890.7 million in Q3 2025.